BRWA
ANGO icon

B. Riley Wealth Advisors’s AngioDynamics ANGO Stock Holding History

B. Riley Wealth Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-54
Closed -$1 – 641
2014
Q4 		$1 Buy
+54
New +$915 ﹤0.01% 3516

Other funds holding ANGO

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMA
Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

B. Riley Wealth Advisors's ANGO Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of AngioDynamics (ANGO) in Q1 2015, closing a stake of 54 shares — an estimated $1 sold.

B. Riley Wealth Advisors first reported a position in ANGO in Q4 2014 and held it in 1 quarter. The position peaked at $1 in Q4 2014. 132 funds tracked by Wall St. Rank hold ANGO as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining AngioDynamics position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 54 AngioDynamics shares in Q1 2015, an estimated $1.
  • B. Riley Wealth Advisors first reported a position in AngioDynamics in Q4 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's AngioDynamics position peaked at $1 in Q4 2014.
  • 132 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.